VSTM - Verastem, Inc.
6.39
0.090 1.408%
Share volume: 899,699
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$6.30
0.09
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 11-06-2024 | 03-20-2025 | 05-13-2025 | 08-07-2025 | 11-04-2025 | 03-04-2026 | |
| Assets | ||||||||
| Total Assets | 105.747 M | 126.378 M | 101.538 M | 131.698 M | 196.264 M | 176.852 M | 246.442 M | |
| Current Assets | 99.646 M | 120.662 M | 94.961 M | 124.699 M | 174.273 M | 154.056 M | 223.413 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 1.168 M | 1.794 M | 1.833 M | |
| Other Current Assets | 825.000 K | 200.000 K | 200.000 K | 200.000 K | 200.000 K | 200.000 K | 200.000 K | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 83.371 M | 113.175 M | 88.818 M | 117.569 M | 164.322 M | 137.706 M | 204.990 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 46.000 K | 39.000 K | 32.000 K | 22.000 K | 21.000 K | 20.000 K | 0.000 | |
| Other Assets | 6.055 M | 5.677 M | 6.545 M | 6.977 M | 21.970 M | 22.776 M | 23.029 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 105.747 M | 126.378 M | 101.538 M | 131.698 M | 196.264 M | 176.852 M | 246.442 M | |
| Total liabilities | 65.737 M | 94.159 M | 130.431 M | 164.131 M | 160.208 M | 192.378 M | 189.245 M | |
| Total current liabilities | 30.347 M | 37.374 M | 30.973 M | 35.619 M | 50.361 M | 59.712 M | 72.268 M | |
| Accounts Payable | 6.678 M | 4.438 M | 4.026 M | 7.199 M | 8.047 M | 9.888 M | 12.448 M | |
| Other liabilities | 0.000 | 26.138 M | 58.734 M | 57.036 M | 35.573 M | 54.542 M | 40.647 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 35.390 M | 30.647 M | 40.724 M | 71.476 M | 74.274 M | 78.124 M | 76.330 M | |
| Other liabilities | 0.000 | 26.138 M | 58.734 M | 57.036 M | 35.573 M | 54.542 M | 40.647 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 18.851 M | 11.060 M | -28.893 M | -32.433 M | 36.056 M | -15.526 M | 57.197 M | |
| Common stock | 885.860 M | 902.036 M | 926.634 M | 968.558 M | 1.064 B | 1.114 B | 1.217 B | |
| Retained earnings | -867.009 M | -890.976 M | -955.527 M | -1.008 B | -1.034 B | -1.132 B | -1.165 B |